Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
Cancer Cell · 2023-03 · 41 (3) · 450-465
DOI: 10.1016/j.ccell.2023.02.014 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Cell, 2023-03. Verfasst von Christopher Tay und 2 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Immunology, Immunology Frontier Research Center (IFReC), Osaka University, Osaka 565-0871, Japan. Hauptthemen laut MEDLINE: T-Lymphocytes, Regulatory, Neoplasms. Die Arbeit wurde bisher 618-mal zitiert (Crossref) und nennt 186 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Government of Japan Ministry of Education Culture Sports Science and Technology.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Experimental Immunology, Immunology Frontier Research Center (IFReC), Osaka University, Osaka 565-0871, Japan.
- Experimental Immunology, Immunology Frontier Research Center (IFReC), Osaka University, Osaka 565-0871, Japan. Electronic address: shimon@ifrec.osaka-u.ac.jp.
Förderung
- Japan Agency for Medical Research and Development
- Government of Japan Ministry of Education Culture Sports Science and Technology
Zitieren
APA
Tay, C., Tanaka, A., & Sakaguchi, S. (2023). Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy. Cancer Cell, 41(3), 450-465. https://doi.org/10.1016/j.ccell.2023.02.014
Vancouver
Tay C, Tanaka A, Sakaguchi S. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy. Cancer Cell. 2023;41(3):450-465. doi:10.1016/j.ccell.2023.02.014
BibTeX
@article{Tay2023,
author = {Tay, Christopher and Tanaka, Atsushi and Sakaguchi, Shimon},
title = {Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy},
journal = {Cancer Cell},
year = {2023},
volume = {41},
number = {3},
pages = {450--465},
doi = {10.1016/j.ccell.2023.02.014}
}
EUVIMED